1.15
—
Close of 9 Nov 2026, in SEK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ortivus
Its shares trade on Nasdaq Stockholm under the ticker ORTI B.ST. It has been listed since 2 January 1997. In the fiscal year to 31 December 2025, it reported revenue of SEK 73.4m and a net loss of SEK 21.9m. At that date it held total assets of SEK 70.9m and shareholders' equity of SEK 22.4m.
Ortivus AB engages in the development and sale of clinical devices and systems. The company is headquartered in Danderyd, Stockholm. The firm is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 2 Jan 1997
- Website
- ortivus.com ↗
Leadership
Pay as last reported
- Ms. Anna-carin StrandbergChairman of the Board, since 2024
- Mr. Gustaf NordenhoekChief Executive Officer
- Mr. Philip SwanChief Executive Officer for Ortivus UK Ltd
- Mr. Gabriel AhbeckDevelopment Manager
- Mr. Per-Ola AnderssonActing Product Manager
- Mr. Jesper EklundHead of Swedish Service and Support
- Mr. Kenneth EklundQuality Manager
- Ms. Joanna TiitusMarketing and Communications Manager
- Hr. Peter EdwallDirectorSEK 150,000
- Mr. Ulf JaernbergDirector
- Ms. Anna Klevby DalgaardDirector
- Ms. Sara LeiDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ortivus AB develops MobiMed Smart for ambulance personnel decision support systems.
- CoroNet mobile surveillance solution enables patient freedom under medical supervision.
- Ortivus AB serves ambulance services and emergency departments with clinical devices.
Weaknesses
- Ortivus AB has no presence in the Information Technology sector beyond health care.
- Ortivus AB lacks products in the Financials or Consumer Discretionary sectors.
- Ortivus AB does not operate in the Materials or Real Estate industries.
Opportunities
- Ortivus AB can expand into the Health Care sector with mobile surveillance solutions.
- Ortivus AB can grow in the Emergency Department segment with MobiMed Smart.
- Ortivus AB can target ambulance services for CoroNet mobile surveillance.
Threats
- Ortivus AB faces competition from Health Care industry players in mobile solutions.
- Ortivus AB must adapt to changing Health Care regulations in Sweden.
- Ortivus AB risks losing market share to new Health Care technology startups.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.